Related references
Note: Only part of the references are listed.TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer
Xi Han et al.
CELL BIOLOGY INTERNATIONAL (2017)
Combinational strategies of metformin and chemotherapy in cancers
Hui-Hui Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells
Masahiro Kai et al.
PLOS ONE (2016)
Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation
Seema Gupta et al.
HELIYON (2016)
Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation
Xianghui He et al.
BMC CANCER (2015)
MUC5AC and MUC5B enhance the characterization of mucinous adenocarcinomas of the lung and predict poor prognosis
Young K. Kim et al.
HISTOPATHOLOGY (2015)
TET1 is controlled by pluripotency-associated factors in ESCs and downmodulated by PRC2 in differentiated cells and tissues
Francesco Neri et al.
NUCLEIC ACIDS RESEARCH (2015)
The Combination of Tet1 with Oct4 Generates High-Quality Mouse-Induced Pluripotent Stem Cells
Jiayu Chen et al.
STEM CELLS (2015)
TET1 Exerts Its Tumor Suppressor Function by Interacting with p53-EZH2 Pathway in Gastric Cancer
Hua-Lin Fu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Tumor-associated mutations in O6-methylguanine DNA-methyltransferase (MGMT) reduce DNA repair functionality
Kristy L. Lamb et al.
MOLECULAR CARCINOGENESIS (2014)
Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation
K. A. Kang et al.
CELL DEATH & DISEASE (2014)
Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
Moritz C. Oberstadt et al.
BMC CANCER (2013)
Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives
Bhawna Gupta et al.
INTERNATIONAL DENTAL JOURNAL (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
Chih-Hung Hsu et al.
CELL REPORTS (2012)
Stromal features are predictive of disease mortality in oral cancer patients
Daniel Marsh et al.
JOURNAL OF PATHOLOGY (2011)
Analysis of RNA from brush cytology detects changes in B2M, CYP1B1 and KRT17 levels with OSCC in tobacco users
Antonia Kolokythas et al.
ORAL ONCOLOGY (2011)
Changes of the O6-methylguanine-DNA methyltransferase promoter methylation and MGMT protein expression after adjuvant treatment in glioblastoma
Tae-Young Jung et al.
ONCOLOGY REPORTS (2010)
ABCG2: A perspective
Robert W. Robey et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Mia Hashibe et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications
C. Scully et al.
ORAL DISEASES (2009)
Current concepts in management of oral cancer - Surgery
Jatin P. Shah et al.
ORAL ONCOLOGY (2009)
Mechanism of Action of Tetrandrine, a Natural Inhibitor of Candida albicans Drug Efflux Pumps
Hong Zhang et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2009)
Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
Yu-Chih Chen et al.
PLOS ONE (2008)
Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa
Keizo Kato et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
MGMT: Its role in cancer aetiology and cancer therapeutics
SL Gerson
NATURE REVIEWS CANCER (2004)
Share Paper
